Concepedia

J.A. Roy

JR

8

Publications

422

Citations

8

H-Index

1996

Active since

Affiliations

National Academies of Sciences, Engineering, and Medicine(Current)

Odense University Hospital

Hôpital du Sacré-Cœur de Montréal

Beatson West of Scotland Cancer Centre

Centre Hospitalier de l’Université de Montréal

J.A. Roy is an author at National Academies of Sciences, Engineering, and Medicine specializing in medicine, inflammation, and oxidative stress.

Top concepts

Publications per year

1996–2020

8

Publications

8

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

Martine Piccart, K. Bertelsen, Gavin Stuart et al. · International Journal of Gynecological Cancer · 2003 · 122 citations

Negative Inotropic and Chronotropic Effects of Oxytocin

Suhayla Mukaddam‐Daher, Yalin Yin, J.A. Roy et al. · Hypertension · 2001 · 120 citations · Full text

Vanilloid (Capsaicin) Receptors Influence Inflammatory Sensitivity in Response to Particulate Matter

Bellina Veronesi, Marga Oortgiesen, J.A. Roy et al. · Toxicology and Applied Pharmacology · 2000 · 47 citations

, , +7

PARTICULATE MATTER INFLAMMATION AND RECEPTOR SENSITIVITY ARE TARGET CELL SPECIFIC

Bellina Veronesi, Colin de Haar, J.A. Roy et al. · Inhalation Toxicology · 2002 · 38 citations

Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer

M. Piccart, K. Bertelsen, Gavin Stuart et al. · International Journal of Gynecological Cancer · 2003 · 35 citations

Rows per page

1–5 of 8